Analyze Diet

Topic:Nutraceuticals

Nutraceuticals in horses refer to dietary supplements that provide health benefits beyond basic nutritional value. These products typically include vitamins, minerals, amino acids, herbs, and other bioactive compounds intended to support various aspects of equine health, such as joint function, digestion, and coat condition. Nutraceuticals are often used to complement traditional veterinary care and may be employed in the management of specific health conditions or to enhance overall well-being. This page compiles peer-reviewed research studies and scholarly articles that explore the composition, efficacy, and safety of nutraceuticals in equine health management.
Evaluation of inflammatory responses induced via intra-articular injection of interleukin-1 in horses receiving a dietary nutraceutical and assessment of the clinical effects of long-term nutraceutical administration.
American journal of veterinary research    July 2, 2009   Volume 70, Issue 7 848-861 doi: 10.2460/ajvr.70.7.848
Pearson W, Orth MW, Lindinger MI.To evaluate inflammatory responses induced via intra-articular recombinant human interleukin (IL)-1beta treatment in horses receiving a dietary nutraceutical (DN; composed of mussel, shark cartilage, abalone, and Biota orientalis lipid extract) and assess the clinical effects of long-term DN administration. Methods: 22 healthy horses. Methods: 12 horses were fed 0, 15, 45, or 75 mg of DN (3 horses/treatment) daily for 84 days. General health and clinicopathologic variables were monitored at intervals. Ten other horses received 0 or 15 g of DN/d (5 horses/treatment) for 29 days (beginning day -...
Simulated digest of a glucosamine-based equine nutraceutical modifies effect of IL-1 in a cartilage explant model of inflammation.
Journal of veterinary pharmacology and therapeutics    May 13, 2008   Volume 31, Issue 3 268-271 doi: 10.1111/j.1365-2885.2008.00946.x
Pearson W, Lindinger MI.No abstract available
An evidence-based approach to selected joint therapies in horses.
The Veterinary clinics of North America. Equine practice    July 10, 2007   Volume 23, Issue 2 443-460 doi: 10.1016/j.cveq.2007.04.007
Richardson DW, Loinaz R.There is an enormous volume of published material about most of the agents used to treat or prevent arthritis in horses. Unfortunately, most of the claims made by nearly all purveyors of arthritis medications in such media are largely unsubstantiated. In addition, the quality of the available information is highly inconsistent, making evidence-based recommendations difficult. This article concentrates on injectable polysulfated glycosaminoglycan, injectable hyaluronan, and the common oral "nutraceuticals".
Double blind investigation of the effects of oral supplementation of combined glucosamine hydrochloride (GHCL) and chondroitin sulphate (CS) on stride characteristics of veteran horses.
Equine veterinary journal. Supplement    April 4, 2007   Issue 36 622-625 doi: 10.1111/j.2042-3306.2006.tb05615.x
Forsyth RK, Brigden CV, Northrop AJ.Oral chondroprotective supplements are commercially popular for veteran (and other athletic or arthritic) horses prone to joint degeneration, yet lack conclusive scientific support. Objective: To quantify the effects of an oral joint supplement (combination glucosamine hydrochloride (GHCL), chondroitin sulphate (CS) and N-acetyl-D-glucosamine) in vivo on stride parameters of veteran horses. Methods: Twenty veteran horses were randomly assigned to a treatment (n = 15) or placebo group (n = 5). Pre-treatment gait characteristics were recorded at trot using digital video footage (50 Hz). The rang...
The use of nutraceuticals for osteoarthritis in horses.
The Veterinary clinics of North America. Equine practice    November 22, 2005   Volume 21, Issue 3 575-vi doi: 10.1016/j.cveq.2005.08.004
Trumble TN.In horses, lameness is often attributable to some degree of osteoarthritis (OA), a complex disease process that is highlighted by eventual degradation of articular cartilage. Conventional therapies for OA in horses are designed to relieve pain and discomfort and often include pharmacologic intervention with nonsteroidal anti-inflammatory drugs or intra-articular steroids. Oral administration of nutraceutical products to the horse is common and easy and is perceived to be a benign treatment for OA in horses. The main goal for use of nutraceuticals is to use them in OA cases to attempt to lower ...
Systemic therapies for joint disease in horses.
The Veterinary clinics of North America. Equine practice    November 22, 2005   Volume 21, Issue 3 547-v doi: 10.1016/j.cveq.2005.07.002
Fortier LA.Systemic therapies for joint disease may be prescribed when a single joint is involved or when multiple sites are affected. The precise therapeutic regimen recommended depends on the duration,cause, and site(s) of injury and is often an adjunct to intra-articular or supportive therapies. If the clinical signs of joint disease are acute and moderate in severity, nonsteroidal anti-inflammatory drugs are often administered to alleviate pain and inflammation. When aiming for more of a generalized maintenance or chondro-protective regimen, an alternative medication, such as hyaluronan,polysulfated ...
Effects of glucosamine hydrochloride and chondroitin sulphate, alone and in combination, on normal and interleukin-1 conditioned equine articular cartilage explant metabolism.
Equine veterinary journal    May 17, 2005   Volume 37, Issue 3 227-231 doi: 10.2746/0425164054530687
Dechant JE, Baxter GM, Frisbie DD, Trotter GW, McIlwraith CW.Clinical trials in human and veterinary literature have documented the benefits of oral nutraceutical joint supplements containing glucosamine (GU) and chondroitin sulphate (CS) to treat mild to moderate osteoarthritis, but the effects of these components have not yet been conclusively determined. Objective: To assess varying dosages of GU and CS on normal and interleukin-1alpha (IL-1) conditioned equine cartilage explants and rationalise the use of these products. Objective: Treatment would not be detrimental to cartilage metabolism and higher dosages and the combination of GU and CS would be...
The role of glucosamine and chondroitin sulfate in treatment for and prevention of osteoarthritis in animals.
Journal of the American Veterinary Medical Association    April 14, 2005   Volume 226, Issue 7 1079-1088 doi: 10.2460/javma.2005.226.1079
Neil KM, Caron JP, Orth MW.No abstract available
Effect of feeding a DHA-enriched nutriceutical on the quality of fresh, cooled and frozen stallion semen.
Theriogenology    February 24, 2005   Volume 63, Issue 5 1519-1527 doi: 10.1016/j.theriogenology.2004.07.010
Brinsko SP, Varner DD, Love CC, Blanchard TL, Day BC, Wilson ME.Eight stallions were used in 2 x 2 crossover study to determine if feeding a nutriceutical rich in docosahexaenoic acid (DHA) would improve semen quality. Stallions were randomly assigned to one of two treatment groups (n = 4 per group). Stallions were fed their normal diet (control) or their normal diet top-dressed with 250 g of a DHA-enriched nutriceutical. Feeding trials lasted for 14 week, after which a 14-week washout period was allowed and the treatment groups were reversed for another 14 week feeding trial. Feeding the nutriceutical resulted in a three-fold increase in semen DHA levels ...
The role of nutritional therapy in the treatment of equine Cushing’s syndrome and laminitis.
Alternative medicine review : a journal of clinical therapeutic    October 10, 2001   Volume 6 Suppl S4-S16 
Harman J, Ward M.Equine Cushing's syndrome, a relatively common and complex condition, is difficult to treat with conventional medicine. Cushing's syndrome involves a hyperplasia or adenoma of the anterior pituitary gland. Biochemical alterations include increased endogenous cortisol, insulin resistance, elevated adrenocorticotrophic hormone, and decreased thyroid hormone levels. Symptoms include hirsutism with no loss of the winter coat in summer, refractory laminitis, weight problems (over- or underweight), polyuria/polydipsia (Pu/Pd), frequent infections, lowered immunity to intestinal parasites, decreased ...
Safety of an oral chondroprotective agent in horses.
Veterinary therapeutics : research in applied veterinary medicine    October 1, 2001   Volume 2, Issue 4 345-353 
Kirker-Head CA, Kirker-Head RP.Six healthy, adult female horses were administered five times the minimum maintenance dose of an oral low-molecular-weight chondroitin sulfate, glucosamine HCl, and manganese ascorbate chondroprotective agent (Cosequin; Nutramax Laboratories, Inc., Edgewood, MD) daily for 35 days. Hematology, serum biochemistry, and synovial fluid parameters were assessed twice prior to administering the product and again at the end of the treatment period. Physical examinations performed daily throughout the study showed no abnormal clinical changes attributable to the product. All hematologic parameters meas...
Oral treatment with a nutraceutical (Cosequin) for ameliorating signs of navicular syndrome in horses.
Veterinary therapeutics : research in applied veterinary medicine    April 1, 2001   Volume 2, Issue 2 148-159 
Hanson RR, Brawner WR, Blaik MA, Hammad TA, Kincaid SA, Pugh DG.Fourteen horses with a progressive forelimb lameness of 3 to 12 months' duration, diagnosed as navicular syndrome, were selected from clinical cases admitted to Auburn University Equine Hospital for evaluation of the efficacy of an orally administered nutraceutical (Cosequin, Nutramax Laboratories, Inc., Edgewood, MD) for ameliorating clinical signs associated with naturally occurring navicular syndrome. Horses were randomly allocated to treatment with the nutraceutical or a placebo. Treatment was five scoops (16.5 g) of powder twice daily in the feed. The test group (n = 8) received a patente...
A review of recent research on nutrition and metabolism in the athletic horse.
Nutrition research reviews    January 1, 1996   Volume 9, Issue 1 149-173 doi: 10.1079/NRR19960010
Hiney KM, Potter GD.Although a lot of research has been directed at attempts to improve performance of the equine athlete, many of the studies reviewed herein did not show statistically significant improvements in race times or increased time to fatigue. However, it must be remembered that success in racing performances is not always measured in time, but by comparative lengths or even by a nose. Therefore, improvement in the ability of an individual equine athlete is not always measurable and success is most frequently determined by one animal being better than the others in a particular competition. Therefore, ...
Common horse sense.
Scientific American    October 1, 1991   Volume 265, Issue 4 12 
Heinrich B.This research article corrects a common misconception about the energy metabolism in horses during short sprinting and long-distance running events, emphasizing that short sprints are primarily powered by anaerobic activity, […]
The use of conventional and unconventional supplements in the Thoroughbred horse.
The Proceedings of the Nutrition Society    January 1, 1989   Volume 48, Issue 1 135-139 doi: 10.1079/pns19890016
Snow DH, Harris RC.No abstract available
Firing horses.
The Veterinary record    September 29, 1979   Volume 105, Issue 13 312 doi: 10.1136/vr.105.13.312
Fraser AC.No abstract available